menu
    • menu

    Company profile for Vor Biopharma

    NEW Drugs in Dev: 5
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vor, the Norse goddess of wisdom, was known as “the careful one.” These qualities are reflected in Vor’s ability to leverage the cumulative knowledge around a variety of recent technologies to carefully craft a new generation of HSCs that are hidden from targeted therapies. Our logo represents the core components of our science — a new approach to hematopoietic stem cells (the crowning triangle) that allows targeted th...
    Vor, the Norse goddess of wisdom, was known as “the careful one.” These qualities are reflected in Vor’s ability to leverage the cumulative knowledge around a variety of recent technologies to carefully craft a new generation of HSCs that are hidden from targeted therapies. Our logo represents the core components of our science — a new approach to hematopoietic stem cells (the crowning triangle) that allows targeted therapies to distinguish between healthy and diseased cells and only attack the target protein (the diamond).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vor BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    215 First Street, Suite 430 Cambridge MA, 02142
    Telephone
    Telephone
    617-655-6580
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vorbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vor-biopharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vor Bio To Present At 44th J.P. Morgan Healthcare Conference
    Vor Bio To Present At 44th J.P. Morgan Healthcare Conference

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213559/0/en/Vor-Bio-to-Participate-in-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Vor Bio Names Levin, Joustra to Board of Directors
    Vor Bio Names Levin, Joustra to Board of Directors

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3210128/0/en/Vor-Bio-Appoints-RA-Capital-s-Andrew-Levin-M-D-Ph-D-and-Forbion-s-Wouter-Joustra-to-Board-of-Directors.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Vor Bio Announces $150 Million Private Placement
    Vor Bio Announces $150 Million Private Placement

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205359/0/en/Vor-Bio-Announces-150-Million-Private-Placement.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Vor Bio Reports Q3 2025 Financials & Corporate Update
    Vor Bio Reports Q3 2025 Financials & Corporate Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187807/0/en/Vor-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Vor Bio Plans $100M Public Stock Offering
    Vor Bio Plans $100M Public Stock Offering

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185064/0/en/Vor-Bio-Announces-Proposed-Public-Offering-of-100-Million-of-Common-Stock.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Telitacicept Hits Primary Endpoint In Ph3 IgA Nephropathy Study
    Telitacicept Hits Primary Endpoint In Ph3 IgA Nephropathy Study

    08 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/08/3184078/0/en/Telitacicept-Achieved-Primary-Endpoint-of-Reducing-Proteinuria-in-Stage-A-of-a-Phase-3-Clinical-Study-for-IgA-Nephropathy-in-China.html

    GLOBENEWSWIRE
    08 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search